Mr Samuel Louis Ciotola Jr, MS, LMFT | |
652 George Washington Hwy, Suite 102, Lincoln, RI 02865-4330 | |
(401) 475-9979 | |
(401) 475-9917 |
Full Name | Mr Samuel Louis Ciotola Jr |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 652 George Washington Hwy, Lincoln, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942235122 | NPI | - | NPPES |
1021740 | Other | RI | GRP # NEIGHBORHOOD HEALTH |
SC42700 | Medicaid | RI | |
413412 | Other | RI | BLUE CHIP |
31348-3 | Other | RI | BLUE CROSS/SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | MFT000094 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Samuel Louis Ciotola Jr, MS, LMFT 23 Mello St, West Warwick, RI 02893-4109 Ph: (401) 787-6926 | Mr Samuel Louis Ciotola Jr, MS, LMFT 652 George Washington Hwy, Suite 102, Lincoln, RI 02865-4330 Ph: (401) 475-9979 |
News Archive
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an animal model that allows them to better understand the mechanisms that lead to the development of multiple myeloma, a hematologic cancer of plasma cells, and the amyloidosis that sometimes accompanies it. The study was published in the journal Scientific Reports.
Decoding the DNA of patients with advanced breast cancer has allowed scientists to identify distinct cancer "signatures" that could help predict which women are most likely to benefit from estrogen-lowering therapy, while sparing others from unnecessary treatment.
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.
Research by the University of Liverpool has found that intervention policies that promote healthy eating could cut the death rate for cardiovascular disease (CVD) by up to 50%.
› Verified 8 days ago
Katherine Weber, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 652 George Washington Hwy, Suite 102, Lincoln, RI 02865 Phone: 401-475-9979 Fax: 401-475-9917 | |
Rebecca Nelson, MS, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1525 Old Louisquisset Pike, B104, Lincoln, RI 02865 Phone: 401-721-5228 |